Amunine
Growth hormone & endocrine
PreclinicalDirect evidence is older endocrine physiology and biochemical purification work, including 1982 pituitary cell and dog studies.
Laboratory, computational, ex vivo or animal model research is the main evidence base.
What is Amunine?
Amunine is a historical pituitary derived peptide reported in older endocrine purification and pituitary cell studies; the catalogue item denotes the research grade material corresponding to the peptide described in early literature.
Which research context has Amunine been associated with?
Amunine is associated with endocrine research of older pituitary physiology and biochemical purification studies, including pituitary cell assays and dog experiments from historical literature exploring endogenous pituitary peptide activity.
What documentation is available for Amunine?
Amunine: Batch documents are not yet linked on this site. For this endogenous pituitary peptide the evidence checklist includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and peptide confirmation; analytical HPLC/UPLC chromatogram with method and purity limits; peptide content and residual solvent/water information; and stability or assay data where applicable. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Amunine?
Amunine: Storage depends on the documented supplied presentation; as an endogenous pituitary peptide ensure whether supplied dry/lyophilised or in solution, solvent or buffer composition, concentration, pH sensitivity, container closure compatibility and freeze/thaw stability are confirmed to address proteolysis, adsorption and chemical degradation risks. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.